Expression of p16INK4a/p16alpha and p19ARF/p16beta is frequently altered in non-small cell lung cancer and correlates with p53 overexpression.

No abstract is available for this paper.

• Publication year

  1998

• Venue

  Oncogene

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 9840942
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The Ink4a tumor suppressor gene product, p19Arf, interacts with MDM2 and neutralizes MDM2's inhibition of p53.

  1998cited by this paper
• p16INK4A Participates in a G1 Arrest Checkpoint in Response to DNA Damage

  1998cited by this paper
• ARF promotes MDM2 degradation and stabilizes p53: ARF-INK4a locus deletion impairs both the Rb and p53 tumor suppression pathways.

  1998cited by this paper
• G1 control gene status is frequently altered in resectable non‐small cell lung cancer

  1997cited by this paper
• Functional analysis of wild-type and malignant glioma derived CDKN2Aβ alleles: Evidence for an RB-independent growth suppressive pathway

  1997cited by this paper
• Frequent aberrant methylation of p16INK4a in primary rat lung tumors

  1997cited by this paper
• Tumor suppression at the mouse INK4a locus mediated by the alternative reading frame product p19ARF.

  1997cited by this paper
• Distinct patterns of inactivation of p15INK4B and p16INK4A characterize the major types of hematological malignancies.

  1997cited by this paper
• Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a.

  1997cited by this paper
• Cancer-associated mutations at the INK4a locus cancel cell cycle arrest by p16INK4a but not by the alternative reading frame protein p19ARF.

  1997cited by this paper
• Adenovirally transferred p16INK4/CDKN2 and p53 genes cooperate to induce apoptotic tumor cell death

  1997cited by this paper
• Splicing into senescence: the curious case of p16 and p19ARF.

  1997cited by this paper
• Alterations of P16 (MTS1) in node‐positive non‐small cell lung carcinomas

  1997cited by this paper
• p16 and p16 beta are potent growth suppressors of head and neck squamous carcinoma cells in vitro.

  1996cited by this paper
• Exclusive p15INK4B gene deletions in acute lymphocytic leukemia include the E1 beta exon of the p16INK4 gene.

  1996cited by this paper
• Regulation of p16CDKN2 expression and its implications for cell immortalization and senescence

  1996cited by this paper
• Prognostic significance of CCND1 (cyclin D1) overexpression in primary resected non-small-cell lung cancer.

  1996cited by this paper
• Role of the INK4a locus in tumor suppression and cell mortality.

  1996cited by this paper
• Genetic evidence in melanoma and bladder cancers that p16 and p53 function in separate pathways of tumor suppression.

  1995cited by this paper
• 5′ CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers

  1995cited by this paper
• High frequency of chromosome 9p allelic loss and CDKN2 tumor suppressor gene alterations in squamous cell carcinoma of the bladder.

  1995cited by this paper
• Alternative reading frames of the INK4a tumor suppressor gene encode two unrelated proteins capable of inducing cell cycle arrest.

  1995cited by this paper
• Complex structure and regulation of the P16 (MTS1) locus.

  1995cited by this paper
• Inactivation of the CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers.

  1995cited by this paper
• Methylation of the 5' CpG island of the p16/CDKN2 tumor suppressor gene in normal and transformed human tissues correlates with gene silencing.

  1995cited by this paper
• A novel p16INK4A transcript.

  1995cited by this paper
• CDKN2 gene silencing in lung cancer by DNA hypermethylation and kinetics of p16INK4 protein induction by 5-aza 2'deoxycytidine.

  1995cited by this paper
• Genomic structure, expression and mutational analysis of the P15 (MTS2) gene.

  1995cited by this paper
• Differential inactivation of CDKN2 and Rb protein in non-small-cell and small-cell lung cancer cell lines.

  1995cited by this paper
• Reciprocal Rb inactivation and p16INK4 expression in primary lung cancers and cell lines.

  1995cited by this paper
• Immunohistochemical detection of the cyclin-dependent kinase inhibitor 2/multiple tumor suppressor gene 1 (CDKN2/MTS1) product p16INK4A in archival human solid tumors: correlation with retinoblastoma protein expression.

  1995cited by this paper
• DNA methylation and cancer.

  1994cited by this paper
• Germline p16 mutations in familial melanoma

  1994cited by this paper
• Differential expression and cell cycle regulation of the cyclin-dependent kinase 4 inhibitor p16Ink4.

  1994cited by this paper
• Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers

  1994cited by this paper
• A cell cycle regulator potentially involved in genesis of many tumor types.

  1994cited by this paper
• Mutations and altered expression of p16INK4 in human cancer.

  1994cited by this paper
• Absence of p16INK4 protein is restricted to the subset of lung cancer lines that retains wildtype RB.

  1994cited by this paper
• Methylation of the oestrogen receptor CpG island links ageing and neoplasia in human colon

  1994cited by this paper
• Parental-origin-specific epigenetic modification of the mouse H19 gene

  1993cited by this paper
• A general method for isolation of high molecular weight DNA from eukaryotes.

  1976cited by this paper

• Molecular mechanisms underlying the regulation of tumour suppressor genes in lung cancer.

  2024cites this paper
• SIRT7 promotes lung cancer progression by destabilizing the tumor suppressor ARF

  2024cites this paper
• Roles of ARF tumour suppressor protein in lung cancer: time to hit the nail on the head!

  2021cites this paper
• P14ARF: The Absence that Makes the Difference

  2020cites this paper
• Post-Translational Regulation of ARF: Perspective in Cancer

  2020cites this paper
• Dual Role of the Alternative Reading Frame ARF Protein in Cancer

  2019cites this paper
• ARF promotes the degradation of the Epidermal Growth Factor Receptor by the lysosome

  2018cites this paper
• Regulatory Network of ARF in Cancer Development

  2018cites this paper
• Novel functions of the p14ARF tumor suppressor: deciphering cell fate at the crossroad of adhesion and survival

  2017cites this paper
• Reduced abundance of the E3 ubiquitin ligase E6AP contributes to decreased expression of the INK4/ARF locus in non–small cell lung cancer

  2017cites this paper
• Differential expression of cellular senescence markers in the assessment of breast cancer development

  2016cites this paper
• Increased expression of senescence markers p14ARF and p16INK4a in breast cancer is associated with an increased risk of disease recurrence and poor survival outcome

  2016cites this paper
• Post-translational Down-regulation of Melanoma Antigen-A11 (MAGE-A11) by Human p14-ARF Tumor Suppressor*

  2015cites this paper
• ARF inhibits the growth and malignant progression of non-small-cell lung carcinoma

  2014cites this paper
• Comparative analyses of individual and multiple alterations of p53, PTEN and p16 in non-small cell lung carcinoma, glioma and breast carcinoma samples.

  2014cites this paper
• p53 protein expression independently predicts outcome in patients with lower-risk myelodysplastic syndromes with del(5q)

  2014cites this paper
• Diagnostic value of the FHIT and p16 mRNA loss and the K-ras gene mutation in pleural fluids for malignant pleural effusion

  2013cites this paper
• p14ARF inhibits the growth of lung adenocarcinoma cells harbouring an EGFR L858R mutation by activating a STAT3-dependent pro-apoptotic signalling pathway

  2013cites this paper
• Molecular diagnosis and prognostic significance of lymph node micrometastasis in patients with histologically node-negative non-small cell lung cancer

  2013cites this paper
• TP53 mutations in myelodysplastic syndromes with deletion of 5q

  2013cites this paper
• The analysis of Bcr-Abl—Nox signalling in chronic myeloid leukaemia

  2013cites this paper
• Using a preclinical mouse model of high-grade astrocytoma to optimize p53 restoration therapy

  2013cites this paper
• Mouse model for probing tumor suppressor activity of protein phosphatase 2A in diverse signaling pathways

  2012cites this paper
• Antitumor activity of type III interferon alone or in combination with type I interferon against human non‐small cell lung cancer

  2011cites this paper
• Concurrent alteration of p16 and PTEN tumor suppressor genes could be considered as potential molecular marker for specific subgroups of NSCLC patients

  2011cites this paper
• Contrôle de la signalisation oncogénique du mutant L858R de l'EGFR par la protéine suppresseur de tumeur p14ARF dans les adénocarcinomes pulmonaires

  2011cites this paper
• Effect of CYP1A1 MSPI polymorphism on the relationship between TP53 mutation and CDKN2A hypermethylation in non-small cell lung cancer.

  2011cites this paper
• The elements of human cyclin D1 promoter and regulation involved

  2011influential citation
• of nearly all morphologic subtypes: potential prognostic implications promoter methylation in adult and childhood acute leukemias p15 Aberrant

  2010cites this paper
• The ARF tumor suppressor: Structure, functions and status in cancer

  2010cites this paper
• The Role of IGF-1 and Notch Signaling in Thoracic Malignancies.

  2010cites this paper
• Inactivation of the p19ARF tumor suppressor affects intestinal epithelial cell proliferation and integrity

  2008cites this paper
• Clinical significance of the p53 pathway and associated gene therapy in non-small cell lung cancers.

  2007cites this paper
• Gene amplification is a relatively frequent event leading to ZBTB7A (Pokemon) overexpression in non‐small cell lung cancer

  2007cites this paper
• Comparison of p16INK4a expression with p53 alterations in head and neck cancer by tissue microarray analysis

  2007cites this paper
• A Translational View of the Molecular Pathogenesis of Lung Cancer

  2007cites this paper
• Homozygous deletions of the INK4a/ARF locus in renal cell cancer.

  2006cites this paper
• The Interactive Transcript Abundance Index [c-myc*p73á]/[p21*Bcl-2] Correlates With Spontaneous Apoptosis and Response to CPT-11: Implications for Predicting Chemoresistance and Cytotoxicity to DNA Damaging Agents

  2006cites this paper
• Role of cell‐cycle regulators in lung cancer

  2005cites this paper
• Methylation status of p14ARF, p15INK4b, and p16INK4a genes in human hepatocellular carcinoma

  2005cites this paper
• Myc Antagonizes Ras-mediated Growth Arrest in Leukemia Cells through the Inhibition of the Ras-ERK-p21Cip1 Pathway*

  2005cites this paper
• Wild-type p53 overexpression and its correlation with MDM2 and p14ARF alterations: an alternative pathway to non-small-cell lung cancer.

  2005cites this paper
• K-ras and p16(INK4A)alterations in sputum of NSCLC patients and in heavy asymptomatic chronic smokers.

  2004cites this paper
• p53 apoptotic pathway molecules are frequently and simultaneously altered in nonsmall cell lung carcinoma

  2004cites this paper
• Expression of Tumor Suppressor Gene Product p14ARF in Endometrioid Adenocarcinoma of the Uterine Corpus

  2004cites this paper
• Future directions: oncolytic viruses.

  2004cites this paper
• p19 Arf Suppresses Growth, Progression, and Metastasis of Hras-Driven Carcinomas through p53-Dependent and -Independent Pathways

  2004cites this paper
• CpG Island Methylation Is Responsible for p14ARF Inactivation and Inversely Correlates with p53 Overexpression in Resected Non–Small Cell Lung Cancer

  2004cites this paper
• Alteration of the p14ARF gene and p53 status in human hepatocellular carcinomas

  2004cites this paper
• Assessment of biological prognostic factors provides clinically relevant information in patients with diffuse large B-cell lymphoma—a Nordic Lymphoma Group study

  2004cites this paper
• Tumor suppressor ARF inhibits HER-2/neu-mediated oncogenic growth

  2004cites this paper
• p14ARF expression in invasive breast cancers and ductal carcinoma in situ – relationships to p53 and Hdm2

  2004cites this paper
• Perturbations of the Ink4a/Arf gene locus in aflatoxin B1-induced mouse lung tumors.

  2003cites this paper
• Ewing’s sarcoma: diagnostic, prognostic, and therapeutic implications of molecular abnormalities

  2003cites this paper
• Concomitant expression of p16INK4a and p14ARF in primary breast cancer and analysis of inactivation mechanisms

  2003cites this paper
• Differentially Expressed Apoptotic Genes in Early Stage Lung Adenocarcinoma Predicted by Expression Profiling

  2003cites this paper
• Alterations in Cell Cycle Genes in Early Stage Lung Adenocarcinoma Identified by Expression Profiling

  2003cites this paper
• Relationship between HPV typing and abnormality of G1 cell cycle regulators in cervical neoplasm.

  2003cites this paper
• Overexpression of p16INK4A and p14ARF in haematological malignancies.

  2003cites this paper
• Pathogenetic and biologic significance of TP14ARF alterations in nonsmall cell lung carcinoma.

  2003cites this paper
• Aberrations of p16INK4A, p14ARF and p15INK4B genes in pediatric solid tumors.

  2003cites this paper
• Aberrant p16 promoter methylation in smokers and former smokers with nonsmall cell lung cancer

  2003cites this paper
• Promoter methylations of p16INK4a and p14ARF genes in early and advanced gastric cancer. Correlations of the modes of their occurrence with histologic type.

  2002cites this paper
• Inactivation of p16INK4a expression in malignant mesothelioma by methylation.

  2002cites this paper
• Aberrant expression of pRb, p16, p14ARF, MDM2, p21 and p53 in stage I adenocarcinomas of the lung

  2002cites this paper
• Growth suppression by a p14ARF exon 1β adenovirus in human tumor cell lines of varying p53 and Rb status

  2002cites this paper
• Germline mutation of ARF in a melanoma kindred.

  2002cites this paper
• Ratio of Expression of p16INK4a to p14ARF Correlates with the Progression of Non‐small Cell Lung Cancer

  2002cites this paper
• Alterations of the p16ink4a gene in resected nonsmall cell lung tumors and exfoliated cells within sputum

  2002cites this paper
• Molecular biology of lung cancer: clinical implications.

  2002cites this paper
• The Liverpool Lung Project: a molecular epidemiological study of early lung cancer detection

  2002cites this paper
• Genetic alterations of INK4alpha/ARF locus and p53 in human hepatocellular carcinoma.

  2002cites this paper
• Live viruses in cancer treatment.

  2002cites this paper
• Ultrastructural and Molecular Heterogeneity in Non-Small Cell Lung Carcinomas: Study of 110 Cases and Review of the Literature

  2002cites this paper
• Association of genetic defects in primary resected lung adenocarcinoma revealed by targeted allelic imbalance analysis.

  2002cites this paper
• Chromosome instability in human lung cancers: possible underlying mechanisms and potential consequences in the pathogenesis

  2002cites this paper
• The expression of cell cycle regulatory proteins in oligodendroglial tumors.

  2002cites this paper
• Alterations of p14ARF, p53, and p73 genes involved in the E2F-1-mediated apoptotic pathways in non-small cell lung carcinoma.

  2001cites this paper
• Evaluation of Methods to Detect p53 Mutations in Ovarian Cancer

  2001cites this paper
• Aberrant expression of tumor suppressor proteins in the Ewing family of tumors.

  2001cites this paper
• The exogenous wild-type p14ARF gene induces growth arrest and promotes radiosensitivity in human lung cancer cell lines

  2001cites this paper
• Infection of Lymphoid Cells by Integration-Defective Human Immunodeficiency Virus Type 1 Increases De Novo Methylation

  2001cites this paper
• Detailed gene expression analysis but not microsatellite marker analysis of 9p21 reveals differential defects in the INK4a gene locus in the majority of head and neck cancers

  2001cites this paper
• The bmi-1 oncoprotein is differentially expressed in non-small cell lung cancer and correlates with INK4A-ARF locus expression

  2001cites this paper
• Alterations of cell cycle regulators are less frequent in advanced non-small cell lung cancer than in resectable tumours.

  2001cites this paper
• Safety and feasibility of injection with an E1B-55 kDa gene-deleted, replication-selective adenovirus (ONYX-015) into primary carcinomas of the pancreas: a phase I trial

  2001cites this paper
• Epigenetic Tumor Markers in Plasma and Serum

  2001cites this paper
• Different expression of P14ARF defines two groups of breast carcinomas in terms of TP73 expression and TP53 mutational status

  2001cites this paper
• Inactivation of both Rb and p53 pathways in mouse lung epithelial cell lines.

  2001cites this paper
• Biological considerations in lung cancer.

  2001cites this paper
• Methylation profiling of human cancers in blood: molecular monitoring and prognostication (review).

  2001cites this paper
• Loss of p16 and/or pRb protein expression in NSCLC. An immunohistochemical and prognostic study.

  2001cites this paper
• Mechanisms of G1 checkpoint loss in resected early stage non-small cell lung cancer.

  2001cites this paper
• Combined analysis of p53 and RB pathways in epithelial ovarian cancer.

  2001cites this paper
• Different p16INK4a and p14ARF Expression Patterns in Acute Myeloid Leukaemia and Normal Blood Leukocytes

  2001cites this paper
• Aberrant Expression of pRb, p16, p14ARF, MDM2, p21 and p53 in Squamous Cell Carcinomas of Lung

  2001cites this paper
• Increased expression of the INK4a/ARF locus in polycythemia vera.

  2001cites this paper
• Patterns of CDKN2A gene loss in sequential oral epithelial dysplasias and carcinomas.

  2001cites this paper
• p14ARF Deletion and Methylation in Genetic Pathways to Glioblastomas

  2001cites this paper
• Immunohistochemical [corrected] detection of the alternate INK4a-encoded tumor suppressor protein p14(ARF) in archival human cancers and cell lines using commercial antibodies: correlation with p16(INK4a) expression.

  2001cites this paper